ClearLabs - Clear Safety

Clear Labs delivers access to genomics, data analytics and actionable insights that protect life.

With fully automated next-generation sequencing and software, we deliver clarity in infectious disease and oncology research.

 

For Research Use Only. Not for use in diagnostic procedures.

Hero Thumbnail

Clinical Diagnostic Solutions

Our comprehensive whole genome sequencing (WGS) platform accelerates detection of infectious disease outbreaks and helps inform the action required to manage public outbreaks.

Food Safety Diagnostic Solutions

We leverage next-generation sequencing (NGS) to completely reinvent the way that food is tested and analyzed before it’s consumed by millions of people each day.

Delivering Clarity

From food safety testing to clinical diagnostics, our team of genomics scientists and software engineers are committed to developing innovative solutions that contribute to pathogen and infectious disease surveillance.

In The News

Clear Labs

Clear Labs is Rebranding our Infectious Disease Portfolio

Clear Labs will be transitioning the name of our infectious disease RUO portfolio from Clear Dx™ to Clear Ix™. This change is part of a broader effort to clearly distinguish our research-use-only (RUO) platforms for infectious diseases...

Read Article

PRWeb

Clear Labs Showcases Oncology NGS Automation Initiatives and Announces Collaboration with Labcorp

Clear Labs announced its expanded automation platform and collaboration with Labcorp to develop streamlined, oncology-focused NGS workflows, marking its move beyond infectious disease sequencing and toward scalable, in-house genomic testing...

Read Article

PRWeb

Clear Labs Unveils Automated Workflow Featuring Pillar Biosciences' SLIMamp® Technology at AMP 2025

Clear Labs announced a new automated workflow featuring Pillar Biosciences' SLIMamp® chemistry on the Clear Dx™ platform, debuting at the AMP Annual Meeting. The collaboration expands Clear Labs' automation technology into oncology, enab...

Read Article

PRWeb

Clear Labs Launches New Fully Automated NGS Platform for Rapid Bacterial and Fungal Detection from Sterile Site Specimens

Clear Labs announced the launch of its newest innovation: an enhanced Clear Dx™ System with additional capabilities and the Clear Dx™ Microbial ID tNGS assay workflow. This end-to-end automated solution enables next-day identification o...

Read Article

Great Entrepreneurs

The Top 50 Healthcare AI Entrepreneurs of 2025

We’re proud to announce that our Co-founder and CEO, Sasan Amini, has been recognized as one of the Top 50 Healthcare AI Entrepreneurs of 2025 by Great Entrepreneurs! This honor highlights the groundbreaking work we’re doing at Clear L...

Read Article

PRWeb

Clear Labs Secures $30 Million in Series D Financing to Accelerate Development and Adoption of Cutting-Edge Sequencing Solutions

This round of financing was led by a strategic investor, along with participation from existing investors, including Counterpoint Global (Morgan Stanley), Felicis, GV, HBM Genomics, Khosla Ventures, Menlo Ventures, Nimble Ventures, Redmile...

Read Article

PRWeb

Clear Labs Launches Microbial Surveillance Whole Genome Sequencing Solution

Clear Labs announces the launch of the Clear Dx™ Microbial Surveillance WGS, a fully-automated, end-to-end whole genome sequencing (WGS) solution for bacterial and fungal isolates.

Read Article

Health Tech World

28 Health Tech Innovations Which are Truly Changing Healthcare

Who is having a real impact on healthcare and digital health? Which innovations will positively affect healthcare in 2023? Here’s the Health Tech World longlist of some of the most prominent names in the space, and Clear Labs is among the...

Read Article

Genome Web

Clear Labs Pushing Automated Whole-Genome Sequencing Into Clinical Market for Infection Control

During the pandemic, Clear Labs expanded the market for its automated sequencing system from environmental pathogen detection in the food industry to SARS-CoV-2 surveillance and wastewater monitoring. Now, the San Carlos, California-based c...

Read Article

BioProcess International

From Immigrant to Entrepreneur: Lessons Learned in Building an Innovative Business

As an entrepreneur, I stepped away from a fulfilling position in a large and established company to go out on my own and build something new. My decision to leave the advanced research department at Illumina, Inc. to create a start-up might...

Read Article
  • Clear Dx®

    Oncology Research Applications Learn About Oncology Research

    Meet Clear Dx®, an automated next-generation sequencing (NGS) platform designed to streamline oncology sequencing workflows. Clear Dx® automates key steps in library preparation and sequencing setup, reducing hands-on time while improving consistency and reproducibility across complex genomic assays. Clear Dx® is designed to support a wide range of oncology research workflows, including targeted sequencing of solid tumor samples, liquid biopsy applications, and fusion detection assays. By simplifying traditionally labor-intensive processes, the platform enables laboratories to efficiently generate high-quality sequencing libraries across multiple assay types while maintaining standardized performance. With automation that scales across diverse oncology workflows, Clear Dx® helps laboratories expand their genomic testing capabilities while accelerating time to insights. The platform also supports streamlined downstream data workflows through compatibility with secondary and tertiary bioinformatics platforms used for variant analysis, interpretation, and results reporting.

    Oncology Research
    • Automated Library Preparation for Oncology Assays

      Automate complex library preparation workflows for oncology sequencing assays, reducing hands-on time while improving workflow consistency.

    • Consistent and Reproducible Results

      Standardized automation minimizes variability and improves reproducibility across complex NGS workflows.

    • Support for Diverse Oncology Workflows

      Run a variety of oncology research applications — including solid tumor sequencing, liquid biopsy workflows, and fusion detection — on a single automated platform.

    • Streamlined Data Workflows

      Designed to integrate with secondary and tertiary bioinformatics platforms, enabling efficient analysis, interpretation, and reporting of genomic results.

  • Clear Ix™

    Infectious Disease Research Applications Learn About Infectious Disease Research

    Meet Clear Ix™, an automated next-generation sequencing (NGS) platform designed to accelerate infectious disease and microbial genomics research. Clear Ix™ streamlines complex sequencing workflows, enabling laboratories to generate high-quality genomic data with minimal hands-on time while improving consistency across runs. By automating key steps in microbial sequencing workflows, Clear Ix™ enables laboratories to efficiently characterize pathogens and generate genomic data for applications such as pathogen surveillance, microbial identification, and genomic epidemiology. Integrated software simplifies data handling and analysis, helping researchers move from sample to actionable insights more quickly.

    Infectious Disease Research
    • Automated Pathogen Sequencing Workflows

      Streamline sequencing workflows for bacterial, viral, and fungal targets with automation designed for modern microbiology laboratories.

    • Consistent and Reliable Results

      Standardized automation improves reproducibility and reduces manual variability across sequencing runs.

    • Comprehensive Microbial Genomics Applications

      Support a wide range of infectious disease research use cases, including pathogen identification, microbial characterization, and genomic surveillance.

    • Simplified Data Analysis

      Integrated software tools streamline data management and analysis, helping laboratories move efficiently from sample to genomic insight.

  • Clear Safety™

    Listeria & Salmonella Testing Learn More

    Whether you’re looking to perform Salmonella serotyping or Listeria persistence monitoring, Clear Safety™ enables deep molecular characterization of pathogens—offering you the flexibility to find the right information for food safety environmental monitoring and quality assurance.

    Learn About Clear Safety™
    • The Power of Data

      Increase operational efficiencies through better decision-making based on insights only achievable with next-generation sequencing (NGS).

    • Automated Workflow

      Maintain reproducibility, reduce hands-on labor and minimize the potential for errors during Salmonella and Listeria sequencing with robotic pipetting and automated bioinformatics.

    • Reliable Results

      Reduce false negatives and false positives—and curtail recall risks, operational costs, holding time, and short-shipping penalties for ​​food safety and quality assurance.

    • Environmental Mapping

      Understand contamination incidents and take more informed corrective actions with the ability to visualize your Listeria environmental monitoring program.